Compound enrofloxacin pellets and preparation method thereof
A technology of enrofloxacin pellets and compound enrofloxacin, which can be applied to pharmaceutical formulations, medical preparations containing active ingredients, organic active ingredients, etc., and can solve the problems of increasing the number of medication, causing stress, poor palatability, etc. problems, to achieve the effect of reducing the dosage of medication, easy to achieve, and convenient to use
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0038] A compound enrofloxacin pellet, comprising a coating and a drug-loaded core, the drug-loaded core is a microparticle with a size not greater than 30 mesh, wherein the drug-loaded core contains the following components by weight percentage:
[0039] Amoxicillin 20%;
[0040] Enrofloxacin 10%;
[0041] Starch 37%;
[0042] Microcrystalline Cellulose 20%;
[0043] Sodium carboxymethyl starch 8%;
[0044] Granulation binder 5%;
[0045] Wherein, the granulation binder is polyvinylpyrrolidone.
[0046] The weight of the coating is 5% of the total weight of the compound enrofloxacin pellets, wherein the coating comprises the following components in percentage by weight:
[0047] Hydroxypropyl Methyl Cellulose 7%;
[0048] Talc 4%.
[0049] The preparation method of described compound enrofloxacin pellets comprises the following specific steps:
[0050] Step 1) Weigh 5g of polyvinylpyrrolidone and dissolve in ethanol or hot water to obtain the granulation binder;
[0...
Embodiment 2
[0055] A compound enrofloxacin pellet, comprising a coating and a drug-loaded core, the drug-loaded core is a microparticle with a size not greater than 30 mesh, wherein the drug-loaded core contains the following components by weight percentage:
[0056] Amoxicillin 30%;
[0057] Enrofloxacin 15%;
[0058] Starch 30%;
[0059] Microcrystalline Cellulose 15%;
[0060] Sodium carboxymethyl starch 5%;
[0061] Granulation binder 5%;
[0062] Wherein, the granulation binder is sodium carboxymethylcellulose.
[0063] The weight of the coating is 5% of the total weight of the compound enrofloxacin pellets, wherein the coating comprises the following components in percentage by weight:
[0064] Hydroxypropyl Methyl Cellulose 10%;
[0065] Talc 2%.
[0066] The preparation method of described compound enrofloxacin pellets comprises the following specific steps:
[0067] Step 1) Weigh 5 g of sodium carboxymethylcellulose and dissolve in hot water to obtain the granulation binder...
Embodiment 3
[0072] A compound enrofloxacin pellet, comprising a coating and a drug-loaded core, the drug-loaded core is a microparticle with a size not greater than 30 mesh, wherein the drug-loaded core contains the following components by weight percentage:
[0073] Amoxicillin 10%;
[0074] Enrofloxacin 5%;
[0075] Starch 43%;
[0076] Microcrystalline Cellulose 25%;
[0077] Sodium Carboxymethyl Starch 10%;
[0078] Granulation binder 7%;
[0079] Wherein, the granulation binder is starch.
[0080] The weight of the coating is 2% of the total weight of the compound enrofloxacin pellets, wherein the coating comprises the following components in percentage by weight:
[0081] Hydroxypropyl methylcellulose 2%;
[0082] Talc 6%.
[0083] The preparation method of described compound enrofloxacin pellets comprises the following specific steps:
[0084] Step 1) Dissolve in hot water after weighing 7g of starch to obtain the granulation binder;
[0085] Step 2) Weigh the following co...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com